AVIR - Atea Pharmaceuticals, Inc.
IEX Last Trade
3.325
0.020 0.602%
Share volume: 14,861
Last Updated: Fri 27 Dec 2024 08:30:28 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$3.30
0.02
0.61%
Summary score
8%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 30-Jun-2015 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2018 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2019
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2015 - 30-Jun-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AVIR | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0% | 8.59% | 20.53% | 4.18% |
| Return on assets | 0% | 3.2% | 11.94% | 3.39% |
| Return on sales | 0% | 22.93% | 42.56% | 26.31% |
| Return on invested capital | 0% | 3.7% | -285.22% | 4.17% |
| Profitability | 0% | 53% | 75% | 53% |
| Total debt ratio | 0% | 72.07% | 53.43% | 56.42% |
| Debt ratio change over time | 0% | -2.55% | -1.24% | 10.92% |
| Dept financing | 0% | 25% | 19% | 45% |
| Current Ratio | 0% | 1.47% | 1.05% | 1.49% |
| Quick Ratio | 0% | 1.16% | 0.74% | 1.19% |
| Cash Position Ratio | 0% | 0.47% | 0.26% | 0.59% |
| Liquididy | 0% | 55% | 45% | 75% |
| Short-term ratios | AVIR | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0% | 22.65% | 18.89% | 6.69% |
| Return on assets | 0% | 3.51% | 11.22% | 3.37% |
| Return on sales | 0% | 24.97% | 42.3% | 25.42% |
| Return on invested capital | 0% | 8.12% | -30.83% | 5.12% |
| Profitability | 0% | 73% | 71% | 46% |
| Total debt ratio | 0% | 83.65% | 54.65% | 60.24% |
| Debt ratio change over time | 0% | 2% | -1.07% | 14.66% |
| Dept financing | 0% | 28% | 16% | 43% |
| Current Ratio | 0% | 1.47% | 1.05% | 1.49% |
| Quick Ratio | 0% | 1.16% | 0.74% | 1.19% |
| Cash Position Ratio | 0% | 0.47% | 0.26% | 0.59% |
| Liquididy | 0% | 69% | 44% | 75% |